In cancer cell models, e.g., pancreatic cancer cells, functional crosstalk of the post-receptor signaling between IGF-I/Insulin receptor with GPCR (e.g., neurotensin receptor and type I angiotensin receptor) has been reported40. This evidence concerns the gene IGF1 and pancreatic neoplasm.